Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects
February 17th, 2016
Here we describe a procedure based on the use of lentiviral particles for the long-term genetic modification of neural stem cells and/or their adjacent ependymal cells in the adult ventricular-subventricular neurogenic niche which allows the separate analysis of cell autonomous and non-autonomous, niche-dependent effects on neural stem cells.
The overall goal of this procedure is to deliver low volumes of high titer lentiviral particles carrying specific DNA constructs to the adult mouse ventricular-subventricular zone to infect all of its cell types or to the lateral ventricle to affect ependymal cells only.This method can help answer key questions about interactions that neural stem cells of the adult ventricular-subventricular niche have with their neighboring ependymal cells.The main advantage of this technique is that lentiviral vectors integrate into the genome of target cells in a cell cycle independent way, allowing for long-term diffication of rarely dividing cells.Helping me to demonstrate the procedure will be grad student Beatriz Mart
View the full transcript and gain access to thousands of scientific videos
Overview
This article describes a procedure utilizing lentiviral particles for the long-term genetic modification of neural stem cells and adjacent ependymal cells in the adult ventricular-subventricular neurogenic niche. This method enables the separate analysis of cell autonomous and non-autonomous, niche-dependent effects on neural stem cells.
Key Study Components
Area of Science
- Neuroscience
- Genetic modification
- Stem cell biology
Background
- Neural stem cells play a crucial role in neurogenesis.
- The ventricular-subventricular zone is a key neurogenic niche in adults.
- Understanding niche-dependent effects is vital for stem cell research.
- Lentiviral vectors are commonly used for stable gene delivery.
Purpose of Study
- To develop a method for long-term genetic modification of neural stem cells.
- To analyze the effects of genetic modifications on stem cell behavior.
- To differentiate between autonomous and non-autonomous influences.
Methods Used
- Use of lentiviral particles for gene delivery.
- Modification of neural stem cells and ependymal cells.
- Analysis of cell behavior in the neurogenic niche.
- Assessment of niche-dependent effects on stem cells.
Main Results
- Successful long-term genetic modification of target cells.
- Identification of distinct effects on neural stem cell behavior.
- Insights into the role of the neurogenic niche.
- Potential implications for stem cell therapies.
Conclusions
- The method provides a valuable tool for studying neural stem cells.
- Understanding niche interactions can inform therapeutic strategies.
- Further research is needed to explore long-term effects.
Frequently Asked Questions
Executive Industry Relevance
Stable genetic modification of adult neural stem cells in the V-SVZ enables precise interrogation of cell-autonomous and non-autonomous mechanisms within a physiologically relevant neurogenic niche. This capability supports predictive confidence in target validation and mechanistic de-risking for CNS-focused discovery programs. The approach enhances translational continuity by modeling long-term gene function in rarely dividing adult stem cell populations.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct manipulation of neural stem cells to clarify gene function in adult neurogenesis.
- Supports mechanistic de-risking by distinguishing cell-autonomous from niche-dependent effects.
- Facilitates hypothesis-driven validation of CNS targets in a native tissue context.
Screening & Assay Development
- Provides a platform for generating genetically defined in vivo models for downstream phenotypic screening.
- Allows for reproducible labeling and tracking of modified cell populations via fluorescent reporters.
- Supports assay standardization by enabling consistent genetic perturbation across experiments.
Translational & Preclinical Research
- Models disease-relevant genetic alterations in adult neural stem cells for translational biomarker discovery.
- Enables longitudinal studies of gene function and cell fate in preclinical neurogenesis models.
- Supports risk-adjusted advancement by providing in vivo evidence of target engagement and biological effect.
Pipeline & Workflow Integration
This method integrates at the interface of early discovery and preclinical validation, bridging in vitro findings with in vivo functional genomics in adult CNS tissue.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification in adult neural stem cell niches.
- Screening: Enables reproducible generation of genetically modified cell populations for downstream assays.
- Analytics: Provides quantitative readouts via fluorescent labeling and cell tracking.
- Translational Research: Aligns with preclinical models for biomarker and target validation in neurogenesis.
- Enterprise Reuse: Establishes a reusable platform for genetic manipulation across CNS discovery programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in CNS target validation.
- Operational Value: Delivers standardized, scalable genetic modification in adult neural stem cell populations.
- Strategic Value: Improves go/no-go decision-making and capital efficiency in neurogenesis-focused portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of CNS targets and mechanisms.
Implementation Considerations
- Requires expertise in stereotaxic injection and lentiviral vector handling.
- Demands access to high-titer viral production and fluorescence imaging infrastructure.
- Necessitates cross-team standardization of injection protocols and readout analysis.
- Adaptation may be needed for different neurogenic niches or animal models.
- Potential limitations include cell-type specificity and efficiency of in vivo transduction.
